Literature DB >> 25118857

Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy.

Takuji Gotoda1, Hideki Ishikawa, Hirohide Ohnishi, Kentaro Sugano, Chika Kusano, Chizu Yokoi, Yutaka Matsuyama, Fuminori Moriyasu.   

Abstract

BACKGROUND: Based on the results of several case-control and cohort studies gastrointestinal X-ray (GI X-ray) has been recommended for use in the nationwide screening program for gastric cancer.. Although this was the only effective screening program when almost all of the Japanese population were Helicobacter pylori (H. pylori) positive, there has been concern whether an alternative effective screening system should be established for the future H. pylori-negative generation. We therefore conducted the first randomized controlled trial (RCT) comparing GI X-ray and gastrointestinal endoscopy (GIE) scheduled according to results of serological testing (ST); this was done to determine the potential for an alternative screening method.
METHODS: Subjects who fulfilled the inclusion criteria were residents between the ages of 30 and 74 and who were able to receive gastric cancer screening in the Yurihonjo area. Participants were assigned to the GI X-ray group or the GIE-ST group by computer randomization. Subjects in each group were further subdivided into 4 categories according to their different risks for gastric cancer. The feasibility of stratified randomization was serologically assessed and detection rates of gastric cancer at entry by the different screening methods were also compared.
RESULTS: Of the 2,962 subjects invited, 1,206 individuals (41 percent) were included in the first stage of this stratified RCT, and 604 and 602 individuals were assigned to the GI X-ray group and the GIE-ST group, respectively. There were no statistically significant differences in sex, age, height, body weight, smoking, alcohol intake and family history of cancer between the 2 groups. During ST the GI X-ray group showed a distribution that was not statistically different from that of the GIE-ST group. Although 3 cases of gastric cancer were detected in the GIE-ST group, there was no statistically significant difference between the 2 groups. One complication found was barium aspiration during the examination in the X-ray group.
CONCLUSION: We confirmed that baseline demographic features of the 2 groups were well balanced. We are now organizing the first RCT to compare the existing screening method and the alternative method (Clinical trial registration number: UMIN000005962).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25118857     DOI: 10.1007/s10120-014-0408-5

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  30 in total

1.  Strategy for eliminating gastric cancer in Japan.

Authors:  Masahiro Asaka; Mototsugu Kato; David Y Graham
Journal:  Helicobacter       Date:  2010-12       Impact factor: 5.753

2.  Comparing mass screening techniques for gastric cancer in Japan.

Authors:  Atsushi Tashiro; Masatoshi Sano; Koichi Kinameri; Kazutaka Fujita; Yutaka Takeuchi
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

3.  Outcomes of mass screening for gastric carcinoma.

Authors:  Chikara Kunisaki; Junko Ishino; Susumu Nakajima; Hisahiko Motohashi; Hirotoshi Akiyama; Masato Nomura; Goro Matsuda; Yuichi Otsuka; Hidetaka Andrew Ono; Hiroshi Shimada
Journal:  Ann Surg Oncol       Date:  2006-01-17       Impact factor: 5.344

4.  Use of Gascon and Pronase either as a pre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: a prospective, randomized, controlled, blinded trial.

Authors:  P Bhandari; S Green; H Hamanaka; T Nakajima; T Matsuda; Y Saito; I Oda; T Gotoda
Journal:  Scand J Gastroenterol       Date:  2010-03       Impact factor: 2.423

5.  No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk.

Authors:  B Riecken; R Pfeiffer; J L Ma; M L Jin; J Y Li; W D Liu; L Zhang; Y S Chang; M H Gail; W C You
Journal:  Prev Med       Date:  2002-01       Impact factor: 4.018

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

7.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Authors:  H Watabe; T Mitsushima; Y Yamaji; M Okamoto; R Wada; T Kokubo; H Doi; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

8.  Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients.

Authors:  G M Naylor; T Gotoda; M Dixon; T Shimoda; L Gatta; R Owen; D Tompkins; A Axon
Journal:  Gut       Date:  2006-04-07       Impact factor: 23.059

Review 9.  Incidence and mortality of gastric cancer in China.

Authors:  Ling Yang
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

10.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

View more
  10 in total

1.  Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan.

Authors:  Shota Saito; Motoi Azumi; Yusuke Muneoka; Katsuhiko Nishino; Takashi Ishikawa; Yuichi Sato; Shuji Terai; Kouhei Akazawa
Journal:  Eur J Health Econ       Date:  2017-05-26

Review 2.  Gastric cancer surgery: historical background and perspective in Western countries versus Japan.

Authors:  Chun-Dong Zhang; Hiroharu Yamashita; Yasuyuki Seto
Journal:  Ann Transl Med       Date:  2019-09

3.  The administrative project of Helicobacter pylori infection screening among junior high school students in an area of Japan with a high incidence of gastric cancer.

Authors:  Chika Kusano; Takuji Gotoda; Hideki Ishikawa; Mitsuhiko Moriyama
Journal:  Gastric Cancer       Date:  2017-01-16       Impact factor: 7.370

4.  Intra-mural distribution of the blood vessels in the stomach demonstrated by contrast medium injection: a cadaver study.

Authors:  Haruka Eishi; Kumiko Yamaguchi; Yoshihiro Hiramatsu; Keiichi Akita
Journal:  Surg Radiol Anat       Date:  2020-11-09       Impact factor: 1.246

5.  Early diagnosis of gastric cancer based on deep learning combined with the spectral-spatial classification method.

Authors:  Yuanpeng Li; Liangyu Deng; Xinhao Yang; Zhao Liu; Xiaoping Zhao; Furong Huang; Siqi Zhu; Xingdan Chen; Zhenqiang Chen; Weimin Zhang
Journal:  Biomed Opt Express       Date:  2019-09-09       Impact factor: 3.732

6.  Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study.

Authors:  Jeung Hui Pyo; Hyuk Lee; Byung-Hoon Min; Jun Haeng Lee; Min Gew Choi; Jun Ho Lee; Tae Sung Sohn; Jae Moon Bae; Kyung-Mee Kim; Joong Hyun Ahn; Keumhee C Carriere; Jae J Kim; Sung Kim
Journal:  Am J Gastroenterol       Date:  2016-01-19       Impact factor: 10.864

Review 7.  Endoscopic gastric cancer screening and surveillance in high-risk groups.

Authors:  Il Ju Choi
Journal:  Clin Endosc       Date:  2014-11-30

8.  Association between Gastric Cancer Risk and Serum Helicobacter pylori Antibody Titers.

Authors:  Mitsutaka Shuto; Toshio Fujioka; Osamu Matsunari; Kazuhisa Okamoto; Kazuhiro Mizukami; Tadayoshi Okimoto; Masaaki Kodama; Shigeru Takigami; Chuichi Seguchi; Yoshihito Nonaka; Ryugo Sato; Yoshio Yamaoka; Kazunari Murakami
Journal:  Gastroenterol Res Pract       Date:  2017-06-11       Impact factor: 2.260

9.  Awareness of risk factors and warning symptoms and attitude towards gastric cancer screening among the general public in China: a cross-sectional study.

Authors:  Qi Liu; Xi Zeng; Wen Wang; Ruo-Lin Huang; Yan-Jin Huang; Shan Liu; Ying-Hui Huang; Ying-Xin Wang; Qing-Hong Fang; Guoping He; Ying Zeng
Journal:  BMJ Open       Date:  2019-07-23       Impact factor: 2.692

10.  Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.

Authors:  HyeIn Jung; Hyun Jung Kim; Eun Sung Choi; Ju Yup Lee; Kyung Sik Park; Kwang Bum Cho; Yoo Jin Lee
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.